First Hawaiian Bank Catalent, Inc. Transaction History

First Hawaiian Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$87.2 - $114.05 $174 - $228	2 Added 0.07%	2,966 $319,000
Q1 2022 Apr 06, 2022	BUY	$94.19 - $124.49 $7,723 - $10,208	82 Added 2.85%	2,964 $329,000
Q4 2021 Jan 12, 2022	BUY	$119.57 - $139.07 $8,250 - $9,595	69 Added 2.45%	2,882 $369,000
Q3 2021 Oct 12, 2021	SELL	$109.17 - $142.35 $3,820 - $4,982	-35 Reduced 1.23%	2,813 $375,000
Q2 2021 Jul 08, 2021	BUY	$100.34 - $115.69 $5,819 - $6,710	58 Added 2.08%	2,848 $308,000
Q1 2021 Apr 09, 2021	BUY	$101.51 - $125.27 $6,598 - $8,142	65 Added 2.39%	2,790 $294,000
Q4 2020 Jan 12, 2021	BUY	$85.88 - $105.36 $15,887 - $19,491	185 Added 7.28%	2,725 $283,000
Q3 2020 Oct 06, 2020	BUY	$72.74 - $92.5 $184,759 - $234,950	2,540 New	2,540 $217,000
Q2 2019 Jul 15, 2019	SELL	$39.26 - $54.21 $26,579 - $36,700	-677 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$29.84 - $43.92 $40,880 - $60,170	-1,370 Reduced 66.93%	677 $27,000
Q4 2018 Jan 11, 2019	SELL	$29.95 - $46.34 $3,444 - $5,329	-115 Reduced 5.32%	2,047 $64,000
Q3 2018 Oct 16, 2018	BUY	$40.12 - $45.55 $86,739 - $98,479	2,162 New	2,162 $99,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.